These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27345470)

  • 1. Re: Basal cell carcinomata: Risk factors for incomplete excision and results of re-excision.
    Robinson AJ; Walsh M; Hill C
    J Plast Reconstr Aesthet Surg; 2016 Nov; 69(11):1564-1565. PubMed ID: 27345470
    [No Abstract]   [Full Text] [Related]  

  • 2. Basal cell carcinomata: Risk factors for incomplete excision and results of re-excision.
    Masud D; Moustaki M; Staruch R; Dheansa B
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):652-6. PubMed ID: 26948998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the treatment of non-melanoma skin cancers by surgical excision.
    Pua VS; Huilgol S; Hill D
    Australas J Dermatol; 2009 Aug; 50(3):171-5. PubMed ID: 19659977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision.
    Griffiths RW
    Br J Plast Surg; 1999 Jan; 52(1):24-8. PubMed ID: 10343586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
    Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
    J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete removal of basal cell carcinoma: what is the value of further surgery?
    Patel SS; Cliff SH; Ward Booth P
    Oral Maxillofac Surg; 2013 Jun; 17(2):115-8. PubMed ID: 22868984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Sampling of Basal Cell Carcinoma Re-excision Specimens: How Much is Enough?
    Mesbah Ardakani N; Harvey NT; Mansford V; Wood BA
    Am J Dermatopathol; 2017 Nov; 39(11):824-828. PubMed ID: 29058693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of residual basal cell carcinoma in re-excised specimens is more probable when deep and lateral margins were positive.
    Fernandes JD; de Lorenzo Messina MC; de Almeida Pimentel ER; Castro LG
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):704-6. PubMed ID: 18384541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the accuracy of the surgeon's diagnosis and significance of positive margins in nonmelanoma skin cancers.
    Hallock GG; Lutz DA
    Plast Reconstr Surg; 2001 Apr; 107(4):942-7. PubMed ID: 11252086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of tumor persistence after incomplete excision of basal cell carcinoma.
    Berlin J; Katz KH; Helm KF; Maloney ME
    J Am Acad Dermatol; 2002 Apr; 46(4):549-53. PubMed ID: 11907506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the appropriate surgical margin for pigmented basal cell carcinoma according to the risk factors for recurrence: a single-institute retrospective study in Japan.
    Nakamura Y; Tanese K; Hirai I; Kameyama K; Kawakami Y; Amagai M; Funakoshi T
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):e453-e455. PubMed ID: 29729096
    [No Abstract]   [Full Text] [Related]  

  • 14. Rate of incomplete excision of basal cell carcinomas by General Practitioners with Special Interest.
    Twist M
    Br J Dermatol; 2009 Jul; 161(1):187. PubMed ID: 19416253
    [No Abstract]   [Full Text] [Related]  

  • 15. Basal cell carcinoma: analysis of regression after incomplete excision.
    Zemelman V; Silva P; Sazunic I
    Clin Exp Dermatol; 2009 Oct; 34(7):e425. PubMed ID: 19686288
    [No Abstract]   [Full Text] [Related]  

  • 16. Basal cell carcinoma: analysis of factors associated with incomplete excision at a referral hospital in southern Spain.
    Husein-Elahmed H; Aneiros-Fernandez J; Gutierrez-Salmeron MT; Aneiros-Cachaza J; Naranjo-Sintes R
    Cutis; 2014 Mar; 93(3):155-61. PubMed ID: 24738098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-excision perineural invasion in basal cell carcinoma.
    Liu C; O'Brien G
    Pathology; 2013 Jun; 45(4):433-5. PubMed ID: 23635825
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal basal cell carcinomas. Can we reduce surgical margins to 3mm with complete excision?
    Konopnicki S; Hermeziu O; Bosc R; Abd Alsamad I; Meningaud JP
    Ann Chir Plast Esthet; 2016 Aug; 61(4):241-7. PubMed ID: 26879668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-excision of incompletely excised cutaneous squamous cell carcinoma: histological findings influence prognosis.
    Bovill ES; Banwell PE
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1390-5. PubMed ID: 22652292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma.
    Huang CC; Boyce SM
    Semin Cutan Med Surg; 2004 Sep; 23(3):167-73. PubMed ID: 15584682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.